Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Correction to: Containing pandemics through targeted testing of households

Fig. 2

Simulation results and effectiveness of targeted pooled household testing (TPHT) on COVID-19. A Fitting the model to Oslo hospitalization data. We plot the mean predicted number of hospitalizations (black) and confidence interval (2σ, dashed). Actual Oslo hospitalizations (red) were used as calibration (until May 15th). Hospitalization data May 15th- August 30th (green) were not used to determine model parameters. B Effect of TPHT in response to a sudden rise in cases (reaching 1000 symptomatic individuals), assuming general infectivity parameters similar to those of Oslo in late May 2020 but with 75% increased infectivity of random contacts giving R = 1.2. C Predicted number of deaths and infections for different TPHT testing fractions corresponding to panel B, relative to no testing. Panels D-F use same parameters as panel B, except with a 113% increased infectivity of random contacts giving R = 1.4. D Effect of test frequency and fraction on R, for TPHT (left) and random pooled household testing (right). Dashed and solid lines indicate isoclines for R = 1 and constant test density, respectively. Optimal point is marked with red circle. E Response of weekly TPHT to varying city size. We scale the population of the baseline Oslo model (γ = 1) to generate larger (γ > 1) or smaller networks with household, school, daycare, workplace and nursing home size-distributions unchanged. F Response of weekly TPHT to changes in distribution of household size, relative to the baseline Oslo model (α = 0). For α > 0, a portion of households are each split into a new pair, yielding a smaller average household size than the baseline. For α < 0, a portion of the households are pairwise merged, yielding a larger average household size than the baseline. Household, school, daycare, workplace and nursing home size-distributions are kept unchanged. G COVID-19 stopping time (number of days until symptomatic cases are reduced by 75%) in response to changing days between tests (left) and fraction of weekly TPHT tests (right). Stopping times longer than 100 days are truncated

Back to article page